Newman Michael James 4
4 · Indaptus Therapeutics, Inc. · Filed Jan 28, 2022
Insider Transaction Report
Form 4
Newman Michael James
DirectorCSO and Director10% Owner
Transactions
- Award
Stock Option (right to buy)
2022-01-26+43,350→ 43,350 totalExercise: $4.90Exp: 2032-01-26→ Common Stock (43,350 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to one-third of the total shares on January 26, 2023 and thereafter the remaining shares vest and become exercisable in equal quarterly installments over the following 24 months.